Peptide therapy TikTok claims: what the science actually says

What did @momospamsmore actually say?

The creator said that MK-677, which they call 'reddit' (likely a nickname), has 'low key cured my ADHD' as an unexpected side effect separate from its appetite suppression effects. They framed it as a personal experience and asked if others felt the same. That framing matters: it's anecdotal, not a recommendation. But 4,900 viewers heard the word 'cured,' and that word does real damage when it's attached to a psychiatric condition.

MK-677, also known as ibutamoren, is a growth hormone secretagogue. It mimics ghrelin and stimulates GH and IGF-1 release. It is not approved by the FDA for any indication and is not a peptide in the strict biochemical sense, though it frequently appears in peptide therapy discussions. The creator is sharing a subjective cognitive experience, not a clinical outcome. That's a meaningful distinction we should not let slip by.

Does the science back this up?

Not in any direct way. There are no published clinical trials examining MK-677's effect on ADHD symptoms in humans. What does exist is indirect and mechanistic at best. MK-677 elevates IGF-1, and some research has looked at IGF-1's role in dopaminergic signaling, which is relevant to ADHD, but that's a long way from 'cured.'

A 2020 review by Arnsten in Neuropsychopharmacology outlined how prefrontal cortex function in ADHD depends heavily on catecholamine signaling, dopamine and norepinephrine specifically. MK-677 does not directly touch those pathways in any well-characterized way. Separately, MK-677's ghrelin-mimicking action has been associated with changes in sleep architecture, including increased REM and slow-wave sleep (Svensson et al., 1998, Journal of Clinical Endocrinology and Metabolism). Poor sleep is a well-documented ADHD amplifier, so improved sleep quality could plausibly explain a subjective sense of sharper focus. That's a reasonable hypothesis, not a mechanism of action for treating ADHD.

What did they get wrong (or right)?

The word 'cured' is wrong, and it should be said plainly. ADHD is a neurodevelopmental condition with a complex genetic and neurobiological basis. No secretagogue has been shown to cure it. Using that word, even casually, sets an expectation that no current evidence supports and could influence someone to deprioritize evidence-based treatment like stimulant medication or behavioral therapy.

What the creator may have gotten partially right is the observation itself. Anecdotes aren't useless. Subjective improvements in focus and executive function are reported by some MK-677 users, and the sleep quality mechanism is at least biologically plausible. Ghrelin receptors are expressed in the brain, including regions involved in cognition (Diano et al., 2006, Nature Neuroscience). The experience is real to the creator. The interpretation, specifically the word 'cured,' is where things go sideways. There's a difference between 'this helped me focus' and 'this cured my ADHD,' and that gap matters clinically and legally.

What should you actually know?

MK-677 is not approved to treat ADHD, and no responsible clinician would prescribe it for that purpose based on current evidence. If you are managing ADHD and curious about why a compound like this might affect your cognition, the most honest answer involves sleep. MK-677 reliably improves slow-wave sleep in multiple studies (Copinschi et al., 1997, Sleep), and sleep deprivation worsens every measurable domain of ADHD symptom severity. So if MK-677 is improving your sleep, you may feel meaningfully better, and that is not nothing, but it is not a cure.

There are also real risks attached to MK-677 that a 15-second TikTok cannot cover: increased appetite and potential weight gain, elevated fasting glucose, water retention, and in some users, increased cortisol. If you are on a regulated telehealth platform and interested in growth hormone secretagogues, that conversation should happen with a licensed provider who has your full metabolic picture, not a comment section.

• MK-677 has no approved indication for ADHD or any psychiatric condition.
• Sleep architecture improvements from MK-677 may explain perceived cognitive benefits.
• Ghrelin receptor activity in the brain is real but not equivalent to ADHD treatment.
• The word 'cured' is not supported by any published clinical evidence.